Image source: Shutterstock
Highlights
MedAdvisor Solutions receives a non-binding offer to acquire its ANZ business for an undisclosed cash sum.
The offer is described as materially higher than the current market valuation of the company.
Binding agreement expected within 5–7 weeks, subject to due diligence.
MedAdvisor Limited (ASX:MDR) has confirmed it has received a non-binding Letter of Intent (LOI) from a major multinational listed software company to acquire its Australia and New Zealand (ANZ) business division. The offer—still confidential in detail—includes a cash consideration that the MedAdvisor board believes represents a significant premium over its current share price.
The strategic development aligns with MedAdvisor’s previously disclosed review of strategic options, a process launched to address the valuation gap between the company’s market capitalisation and the board’s internal assessment of the fair value of its ANZ and US operations.
According to MedAdvisor, the ANZ business continues to perform strongly, recording record revenue of AU$2.9 million in April 2025. This strong performance likely helped catalyse interest from potential buyers, leading to what CEO Rick Ratliff described as a "compelling offer".
“We are pleased to have received a compelling offer which validates our view of the significant strategic value of MedAdvisor Solutions' ANZ business,” said Ratliff. “We are also very pleased that our process has identified a potential acquirer that intends to continue to grow and invest in the business for the benefit of pharmacies across Australia.”
The LOI includes standard provisions, including a period of exclusivity for due diligence. However, MedAdvisor noted that significant preliminary work has already been completed by both parties, allowing for an expected execution of a binding sale and purchase agreement within 5 to 7 weeks.
The identity of the suitor has not been disclosed, but the company is described as a prominent global software player with Australian operations.
MedAdvisor continues to be supported in this process by Adelaide Equity Partners Limited (AE Advisors) and legal advisors HWL Ebsworth, who are assisting in evaluating the proposal and broader strategic options.






Please wait processing your request...